Litcius/Paper detail

Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials

Yuan Zhang, Guanhua Chen, Weimin Wang, Donghui Yang, Dalong Zhu, Yali Jing

2024Bone32 citationsDOI

Topics & Concepts

Type 2 diabetesRandomized controlled trialMedicineInternal medicineMeta-analysisGlucagon-like peptide 1 receptorGlucagon-like peptide-1PharmacologyEndocrinologyReceptorDiabetes mellitusAgonistDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsBone health and osteoporosis research
Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials | Litcius